Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

Clinical trial NCT05318534 · RECRUITING

Trial details

NCT number: NCT05318534
Sponsor: Gliknik Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

First in Man Study to Evaluate Initial Safety

Start date: 2022-04-08
Primary completion: 2026-06-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.